AAAAAA

   
Results: 1-17 |
Results: 17
Role of P-glycoprotein and organic anion transporting polypeptides in drugabsorption and distribution - Focus on H-1-receptor antagonists
Authors: Hansten, PD Levy, RH
Citation: Pd. Hansten et Rh. Levy, Role of P-glycoprotein and organic anion transporting polypeptides in drugabsorption and distribution - Focus on H-1-receptor antagonists, CLIN DRUG I, 21(8), 2001, pp. 587-596
Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin
Authors: Ragueneau-Majlessi, I Levy, RH Meyerhoff, C
Citation: I. Ragueneau-majlessi et al., Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin, EPILEPSY R, 47(1-2), 2001, pp. 55-63
Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers
Authors: Levy, RH Ragueneau-Majlessi, I Baltes, E
Citation: Rh. Levy et al., Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers, EPILEPSY R, 46(2), 2001, pp. 93-99
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
Authors: Bialer, M Johannessen, SI Kupferberg, HJ Levy, RH Loiseau, P Perucca, E
Citation: M. Bialer et al., Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V), EPILEPSY R, 43(1), 2001, pp. 11-58
Fluvoxamine-theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2
Authors: Yao, CP Kunze, KL Kharasch, ED Wang, Y Trager, WF Ragueneau, I Levy, RH
Citation: Cp. Yao et al., Fluvoxamine-theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2, CLIN PHARM, 70(5), 2001, pp. 415-424
Nefopam enantiomers: Preclinical pharmacology/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administration
Authors: Mather, GG Labroo, R Le Guern, ME Lepage, F Gillardin, JM Levy, RH
Citation: Gg. Mather et al., Nefopam enantiomers: Preclinical pharmacology/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administration, CHIRALITY, 12(3), 2000, pp. 153-159
Development of a semi-quantitative assay to detect full-length CYP2C19 RNA
Authors: Wang, XY Levy, RH Ho, RJY
Citation: Xy. Wang et al., Development of a semi-quantitative assay to detect full-length CYP2C19 RNA, BIOTECHNIQU, 29(2), 2000, pp. 364
Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid
Authors: Spiegelstein, O Kroetz, DL Levy, RH Yagen, B Hurst, SI Levi, M Haj-Yehia, A Bialer, M
Citation: O. Spiegelstein et al., Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid, PHARM RES, 17(2), 2000, pp. 216-221
Reply to David Wyman (Bombing of Auschwitz)
Authors: Levy, RH
Citation: Rh. Levy, Reply to David Wyman (Bombing of Auschwitz), HOLOC GENOC, 13(3), 1999, pp. 536-536
A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin
Authors: Rettie, AE Haining, RL Bajpai, M Levy, RH
Citation: Ae. Rettie et al., A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin, EPILEPSY R, 35(3), 1999, pp. 253-255
Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)
Authors: Bialer, M Johannessen, SI Kupferberg, HJ Levy, RH Loiseau, P Perucca, E
Citation: M. Bialer et al., Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV), EPILEPSY R, 34(1), 1999, pp. 1-41
Effect of stiripentol dose on phenytoin-induced teratogenesis in a mouse model
Authors: Finnell, RH Bennett, GD Mather, GG Wlodarczyk, B Bajpai, M Levy, RH
Citation: Rh. Finnell et al., Effect of stiripentol dose on phenytoin-induced teratogenesis in a mouse model, REPROD TOX, 13(2), 1999, pp. 85-91
Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid
Authors: Spiegelstein, O Yagen, B Levy, RH Finnell, RH Bennett, GD Roeder, M Schurig, V Bialer, M
Citation: O. Spiegelstein et al., Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid, PHARM RES, 16(10), 1999, pp. 1582-1588
Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450
Authors: Erickson, DA Mather, G Trager, WF Levy, RH Keirns, JJ
Citation: Da. Erickson et al., Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450, DRUG META D, 27(12), 1999, pp. 1488-1495
Valproate
Authors: Shen, DD Levy, RH
Citation: Dd. Shen et Rh. Levy, Valproate, HANDB EXP P, 138, 1999, pp. 359-373
Cytotoxicity induced by the combination of valproic acid and tumor necrosis factor-alpha - Implication for valproic acid-associated hepatotoxicity syndrome
Authors: Yao, CP Mather, GG Stephens, JR Levy, RH
Citation: Cp. Yao et al., Cytotoxicity induced by the combination of valproic acid and tumor necrosis factor-alpha - Implication for valproic acid-associated hepatotoxicity syndrome, BIOCH PHARM, 58(3), 1999, pp. 455-459
Late Neogene Sirius Group strata in Reedy Valley, Antarctica: a multiple-resolution record of climate, ice-sheet and sea-level events
Authors: Wilson, GS Harwood, DM Askin, RA Levy, RH
Citation: Gs. Wilson et al., Late Neogene Sirius Group strata in Reedy Valley, Antarctica: a multiple-resolution record of climate, ice-sheet and sea-level events, J GLACIOL, 44(148), 1998, pp. 437-447
Risultati: 1-17 |